Vaxess Technologies INC.
Life science company developing vaccines and therapeutics.
Based in MA
🤖
AI Overview
With $350K in lobbying spend across 14 quarterly filings, Vaxess Technologies INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2024.
$350K
Total Spend
4
Years Active
1
Firms Hired
8
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $50K |
| 2022 | $120K |
| 2023 | $120K |
| 2024 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Science/Technology, Budget/Appropriations
- •Issues related to the investment and commercialization of synthetic biology applications.
- •Appropriations.
- •FY 2022 Appropriations.
- •Issues related to the investment and commercialization of synthetic biology applications.
- •General education on Vaxess.
- •COVID-19 Response.
Related Analysis
Related Investigations
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.